Top Tech Startups in Jordan, JO in 2024

Valory makes AI software that groups of people or organizations can control together. This creates new opportunities in web3, science, and enterprise ventures, and means powerful AI systems can be owned by everyone. We co-created Olas, the platform for co-owning AI, specifically autonomous AI agents, coordinated by the OLAS token. It's made up of the Olas Stack, an open-source framework for building the agents and the Olas Protocol, a blockchain protocol for incentivizing the agents. We believe AGI will be agentic and must be co-owned. We are proving that the majority of crypto users will be AI agents, and they're already here.

We are the internet platform for the greater Middle East region. A pioneer of the region's ride-hailing economy, we are expanding services across its platform to include mass transportation, delivery and payments to become the region's everyday SuperApp. We were established in July 2012, and acquired by Uber in 2019. We operates in 120 cities across 15 countries and have created more than one million employment opportunities in the region.

Spiritual Data helps people of all beliefs to unite in an unbiased examination of truth. We do this through relating spiritual experiences and research to spiritual hypotheses and using statistical methods to determine the most likely conclusions. Technology automates this process.

We are Wunderman Thompson -- a creative, data and technology agency built to inspire growth for ambitious brands.

ATLAS ANALYTICS is one of the leading tech-enabled startups for B2B remote sales and business development solutions. We run thoughtful campaigns for our clients generating opportunities and meaningful relationships. Our approach is data-driven, fully customised and transparent. With our network across the globe, we are experts at getting to the right people, opening doors for our clients, so that they can focus on what they do best.

Nabta Health (nabtahealth.com) discovers new ways for women to prevent, identify and manage non-communicable diseases (NCDs). The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. NCDs also leave populations more susceptible to communicable diseases such as COVID-19. Moreover, NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Today, women using drugs that were approved pre-1994, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Standardising and personalising the ways in which women identify and manage NCDs in the context of their own lifestyles and health goals, and through the use of applied machine learning and Artificial Intelligence, will improve clinical outcomes and make cutting-edge healthcare affordable and accessible for all women. Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to obtain a formal diagnosis of PCOS within 90 days versus the global average of 2.5 years.